Back
Cellectis SA Vs. Akari Therapeutics PLC Industry Stock Comparison
Sell
29
CLLS
Cellectis SA
Last Price:
1.89
Seasonality Move:
11.03%
Sell
33
AKTX
Akari Therapeutics PLC
Last Price:
2.95
Seasonality Move:
-19.38%
Sell
29
Cellectis SA (CLLS)
is a Sell
Is Cellectis SA a Buy, Sell or Hold?
- The current Cellectis SA [CLLS] share price is $1.89. The Score for CLLS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- CLLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $3.01. The Score for AKTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLLS Stock Price Chart
What is Cellectis SA's stock price today?
-
The Cellectis SA share price today is $1.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing selling pressure, which indicates risk of future bearish movement.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $3.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 30.12 | Sell |
Chaikin Money Flow: | -65873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.08 - 2.34) | Sell |
Bollinger Bands (100): | (1.97 - 2.57) | Sell |
AKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 40.68 | Sell |
Chaikin Money Flow: | 3391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.01 - 3.47) | Sell |
Bollinger Bands (100): | (2.38 - 3.8) | Sell |
CLLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.06 | Sell |
20-day SMA: | 2.19 | Sell |
50-day SMA: | 2.2 | Sell |
200-day SMA: | 2.54 | Sell |
8-day EMA: | 2.04 | Sell |
20-day EMA: | 2.14 | Sell |
50-day EMA: | 2.2 | Sell |
200-day EMA: | 2.37 | Sell |
AKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.02 | Sell |
20-day SMA: | 3.16 | Sell |
50-day SMA: | 3.45 | Sell |
200-day SMA: | 2.61 | Buy |
8-day EMA: | 3.04 | Sell |
20-day EMA: | 3.16 | Sell |
50-day EMA: | 3.26 | Sell |
200-day EMA: | 3.16 | Sell |
Cellectis SA Earnings Growth & CLLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.35 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Cellectis SA Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akari Therapeutics PLC Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |